of genomics in exercise prescription Last Word on Viewpoint: Perspective on the future use
暂无分享,去创建一个
Stephen M. Roth | Linda S. Pescatello | Matthew A. Kostek | Monica J. Hubal | L. Pescatello | S. Roth | Monica Jeanne Hubal
[1] L. Bradley,et al. Why should genomic medicine become more evidence-based? , 2007, Genomic Medicine.
[2] C. Bouchard,et al. Cardiorespiratory fitness, BMI, and risk of hypertension: the HYPGENE study. , 2007, Medicine and science in sports and exercise.
[3] R. Redon,et al. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.
[4] B. Materson. Variability in response to antihypertensive drugs. , 2007, The American journal of medicine.
[5] R. Fagard,et al. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. , 2006, European heart journal.
[6] C. Bouchard,et al. Individual differences in response to regular physical activity. , 2001, Medicine and science in sports and exercise.
[7] L. Cardon,et al. Population stratification and spurious allelic association , 2003, The Lancet.
[8] G. Beunen,et al. Genetic determinants of sports participation and daily physical activity , 1999, International Journal of Obesity.
[9] P. Thompson,et al. Dietary calcium intake and Renin Angiotensin System polymorphisms alter the blood pressure response to aerobic exercise: a randomized control design , 2007, Nutrition & metabolism.
[10] M. Fraga,et al. The Epigenetic Basis of Twin Discordance in Age-Related Diseases , 2007, Pediatric Research.
[11] S. Roth. Perspective on the future use of genomics in exercise prescription. , 2008, Journal of applied physiology.